- the data needed to properly evaluate Covid-19 vaccine booster shots for the general population is limited says a CDC scientist
- President Joe Biden is asking health officials to clear the shots for wide distribution beginning the week of Sept. 20
- Oliver’s presentation at a Centers for Disease Control and Prevention advisory group meeting suggests the panel may limit its initial endorsement of extra shots to vulnerable groups and healthcare workers
A CDC scientist said Monday the data needed to properly evaluate Covid-19 vaccine booster shots for the general population is limited — even as President Joe Biden pressures health officials to clear the shots for wide distribution beginning the week of Sept. 20 says an article on CNBC.
Booster shots limited
The presentation by Dr. Sara Oliver at a Centers for Disease Control and Prevention advisory group meeting suggests the panel may limit its initial endorsement of extra shots to vulnerable groups and healthcare workers.
The vaccine prevents severe disease
Several studies suggest the authorized Covid vaccines remain effective in preventing severe disease and hospitalization but may be less effective in preventing infection or mild symptomatic illness, according to Oliver.
Vote on approval of the vaccine
The CDC’s Advisory Committee on Immunization Practices is meeting Monday to consider booster shots for all eligible Americans. The panel is also scheduled to vote on endorsing the Food and Drug Administration’s final approval of Pfizer’s vaccine.
Priority group
Once booster shots are available, nursing home residents, healthcare providers, and the elderly — the first groups to get vaccinated in December and January — are likely to be prioritized for the extra shots, the CDC slides suggested.
Did you subscribe to our daily newsletter?
It’s Free! Click here to Subscribe!
Source: CNBC
